Realizing the potential of nanomedicines to treat breast cancer liver metastasis

Biana Godin^{1

2

3}, Hermann B Frieboes^{4

5

6

7}

Affiliations

¹ Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.
² Department of Obstetrics and Gynecology, Weill Cornell Medicine College, New York, NY, USA.
³ Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.
⁴ Department of Bioengineering, University of Louisville, Louisville, KY, USA.
⁵ Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, USA.
⁶ UofL Health - Brown Cancer Center, University of Louisville, Louisville, KY, USA.
⁷ Center for Predictive Medicine, University of Louisville, Louisville, KY, USA.

PMID: 40013682
PMCID: PMC12068325 (available on 2026-02-27)
DOI: 10.1080/17435889.2025.2469491

Editorial

Realizing the potential of nanomedicines to treat breast cancer liver metastasis

Biana Godin et al. Nanomedicine (Lond). 2025 May.

. 2025 May;20(10):1073-1076.

doi: 10.1080/17435889.2025.2469491. Epub 2025 Feb 27.

Authors

Biana Godin^{1

2

3}, Hermann B Frieboes^{4

5

6

7}

Affiliations

¹ Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.
² Department of Obstetrics and Gynecology, Weill Cornell Medicine College, New York, NY, USA.
³ Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.
⁴ Department of Bioengineering, University of Louisville, Louisville, KY, USA.
⁵ Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, USA.
⁶ UofL Health - Brown Cancer Center, University of Louisville, Louisville, KY, USA.
⁷ Center for Predictive Medicine, University of Louisville, Louisville, KY, USA.

PMID: 40013682
PMCID: PMC12068325 (available on 2026-02-27)
DOI: 10.1080/17435889.2025.2469491

No abstract available

Keywords: Liver metastasis; breast cancer; macrophages; nanomedicine; nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

1. Diamond JR, Finlayson CA, Borges VF.. Hepatic complications of breast cancer. Lancet Oncol. 2009. Jun;10(6):615–621. - PubMed
1. Liu C, Mohan SC, Wei J, et al. Breast cancer liver metastasis: Pathogenesis and clinical implications. Front Oncol. 2022;12:1043771. - PMC - PubMed
1. Cummings MC, Simpson PT, Reid LE, et al. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014. Jan;232(1):23–31. - PMC - PubMed
1. Ji L, Cheng L, Zhu X, et al. Risk and prognostic factors of breast cancer with liver metastases. BMC Cancer. 2021. Mar 6;21(1):238. - PMC - PubMed
1. Xie J, Xu Z.. A population-based study on liver metastases in women with newly diagnosed breast cancer. Cancer Epidemiol Biomarkers Prev. 2019. Feb;28(2):283–292. - PubMed

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Realizing the potential of nanomedicines to treat breast cancer liver metastasis

Affiliations

Realizing the potential of nanomedicines to treat breast cancer liver metastasis

Authors

Affiliations

Conflict of interest statement

References

Publication types